Little is known regarding factors associated with soluble amyloid beta peptide (Ab) concentrations in humans at late midlife, when Ab is likely most critical to Alzheimer disease pathogenesis. We examined the association between insulin, insulin-related factors, and plasma Ab at late midlife. Plasma Ab42, Ab40, fasting insulin, and c-peptide were measured in 468 women without diabetes, aged 59 to 69 years (median 63 y). Before blood draw, participants reported body mass index, waist circumference, physical activity, alcohol intake, hypertension, and diabetes family history. Linear regression was used to calculate ageadjusted mean differences in Ab42 to Ab40 ratio, and Ab42 levels, by insulin and insulin-related factors. The ratio of Ab42 to Ab40 was statistically significantly lower in women with family history of diabetes, and Ab42 was significantly lower with less physical activity, greater waist circumference, hypertension, and family history of diabetes (P<0.05 for all). Ab42 to Ab40 ratio, and Ab42 levels, appeared lower with higher c-peptide levels (P trend=0.07 and 0.06, respectively), although these were not statistically significant. In summary, insulin-related factors appear associated with lower plasma Ab42 to Ab40 ratio, and Ab42, at late midlife, consistent with increased brain sequestration of Ab42 (relative to Ab40), suggesting insulin merits focus in strategies to prevent dementia.
I nsoluble amyloid plaques in the brain regions important for memory and cognition are a pathologic hallmark of Alzheimer disease (AD). The plaques are predominantly composed of 2 forms of amyloid-b peptide (Ab), one with 42 amino acids (Ab42) and the other with 40 amino acids (Ab40); however, Ab42 seems to be the key peptide involved in plaque initiation and growth. 1, 2 Cerebral accumulation of Ab42 likely begins at least 10 to 15 years before the onset of clinical symptoms. 3, 4 Therefore, identifying early determinants of Ab42 accumulation may lead to ways to help stem the growing epidemic of AD. 2 Surprisingly little is known regarding factors that may regulate Ab levels in apparently healthy individuals. Several lines of evidence suggest that insulin and factors that affect insulin levels might mediate levels of circulating Ab. For example, insulin-degrading enzyme (IDE) preferentially binds to insulin over its other peptide substrates, including Ab 5,6 ; thus, it is possible that high steady-state levels of insulin in the brain lead to greater Ab42 accumulation and gradual deposition into insoluble plaques, and consequently lower levels of circulating Ab42. In addition, several small clinical studies reported decreases in plasma Ab42 levels, and in the ratio of plasma Ab42 to Ab40, in cognitively healthy adults who received either intravenous or intranasal doses of insulin, suggesting that high levels of insulin in the periphery and the brain might similarly impact Ab homeostasis. 7, 8 We investigated whether insulin and insulin-related factors were associated with Ab42 levels and the ratio of Ab42 to Ab40 in plasma at late midlife in a cross-sectional study of 468 women without type 2 diabetes in the Nurses' Health Study (NHS) . Although there are multiple sources contributing to Ab levels in plasma, the brain is its principal source and evidence indicates that Ab levels in plasma reflect those in the brain. [9] [10] [11] For example, studies administering anti-Ab antibody to mice and humans both found reduced plaque deposition and increased plasma Ab levels. 9, 11 Moreover, 5 of 6 large prospective studies of plasma Ab [12] [13] [14] [15] [16] [17] all found higher risks of cognitive decline and dementia among adults with lower plasma levels of Ab42 relative to Ab40, or a decrease in this ratio over time, likely reflecting a higher rate of sequestration of Ab42 versus Ab40 into insoluble deposits in the brain. 18 
METHODS

NHS
The NHS was initiated in 1976 when 121,700 female registered nurses ages 30 to 55 years returned a mailed questionnaire about their medical history and lifestyle. Participants have updated this information on biennial mailed questionnaires. This study was approved by the institutional review board of Brigham and Women's Hospital. Participants provided informed consent by returning their questionnaires.
From 1989 to 1990, 32,826 participants, aged 43 to 69 years, provided a blood sample. After arranging to have their blood drawn, women mailed the blood samples with an ice pack to our laboratory via overnight mail. Less than 5% of the samples were received more than 26 hours after being drawn. Whole blood samples were centrifuged and aliquoted into plasma, red blood cells, and white blood cells, and have been stored at À1301C in liquid nitrogen freezers. Women who provided blood samples were similar to the whole cohort in several key characteristics assessed at the time of blood draw, including mean age (56 vs. 55 y, respectively), mean body mass index (BMI; 25 kg/m 2 in both groups), mean alcohol intake (6 g/d in both groups), and family history of diabetes (30% vs. 26%, respectively).
Population for Analysis
We conducted these analyses among women who were part of the NHS cognitive substudy. The cognitive substudy was initiated from 1995 to 2001, when 22,715 NHS participants aged 70 years and older and free of diagnosed stroke were invited to participate in a telephone cognitive assessment. We obtained the present study sample (n=500) by first oversampling participants from the top and bottom 20% of the distributions of cognitive decline in our population and then by selecting random participants from the remainder of the distribution. We also excluded women who reported type 2 diabetes for several reasons. Specifically, insulin and insulin-related factors are complex in those with diabetes; many women make lifestyle changes in insulin-related factors (eg, diet, weight, physical activity) in response to a diabetes diagnosis, which could lead to misclassification of long-term exposure status. In addition, insulin levels among adults with diabetes vary for multiple reasons, such as disease severity and duration, complications, and use of medications, and thus it is extremely difficult to disentangle insulin levels from disease state or medication use. Thus, overall, it would be difficult to interpret the direct, independent relation of insulin and insulin-related factors to Ab levels in those with diabetes. Finally, midlife levels of plasma Ab40 or Ab42 for 32 women were below the limit of detection; thus, the population for analysis included 468 women.
Detailed Protocol for Ab Assays
We assayed plasma Ab40 and Ab42 by sandwich enzyme-linked immunosorbent assay. Nunc MaxiSorp 384well plates were coated with capture antibodies (2G3 for Ab40 and 21F12 for Ab42) in phosphate-buffered saline (PBS) and incubated for 4 hours at room temperature (RT), then blocked overnight at 41C. Plates were washed 3 times with PBS containing tween 20, and samples were loaded into the wells and incubated for 4 hours at RT. Samples were then incubated with detector antibody (biotinylated 266 to the mid-region of Ab) for 2 hours at RT. Finally, samples were incubated with streptavidin AP (Promega, Madison, WI) in PBS for 1 hour at RT and washed 3 times with tris-buffered saline. The signal was amplified with AttoPhos (Promega, Madison, WI) and measured with a Victor2 fluorescent plate reader (PerkinElmer, Boston, MA).
Reliability of Plasma Ab Assays
Before beginning this study, we established that plasma Ab measurements would yield reliable and valid results with the specific blood collection and storage procedures used in the NHS. For example, although only a small percentage of the NHS samples were processed more than 24 hours after blood draw, intraclass correlations were >0.95 for Ab40 and Ab42 after processing delays of up to 48 hours, indicating stability of Ab levels with delayed processing. 19 During this study, a total of 7 plates were used for the immunosorbent assays, and blinded duplicate quality control pairs were included on each plate. High between-plate variability appeared to contribute to high overall coefficients of variation (CVs) for the quality control samples (45.0% for Ab40 and 34.7% for Ab42). However, after separating between-plate and within-plate variabilities, the average within-plate CV was only 10.2%. Thus, as described below, all analyses were conducted based on within-plate comparisons.
Measurement of Plasma Insulin and c-peptide and Insulin-related Variables
All of the women had provided fasting (Z8 h) blood samples. Plasma insulin was measured using a radioimmunoassay (Linco, St Louis, MO). Plasma c-peptide, a marker of insulin production, was measured using antiserum M1230 in an alcohol precipitation nonequilibrium assay (Faber et al, 1978) with reagents provided by Diagnostic Systems Laboratory (Webster, TX). In blinded quality control tests that we conducted, mean intra-assay CVs were 5.1% for c-peptide and 5.9% for insulin.
Self-reported information on all insulin-related factors, except waist circumference, was current as of the questionnaire closest, but before, the date of blood draw (ie, either the 1988 or 1990 questionnaire). For waist circumference, participants were given instructions in 1986 for taking this measurement; 375 women in this analysis provided this information. Physical activity, defined as metabolic equivalent hours per week, was derived from the average time per week spent participating in various recreational activities during the past year. Information on alcohol intake was collected using semi-quantitative food frequency questionnaires. Items on typical beer, wine, and liquor consumption during the past year were used to calculate average grams of alcohol consumed per day. Validation studies have established that these nurses' selfreports of various health indicators, including height, weight, waist circumference, physical activity, and alcohol consumption, are highly accurate. [20] [21] [22] [23] 
Statistical Analysis
For these analyses, we examined plasma insulin, plasma c-peptide, waist circumference, and physical activity as categorical variables using quartile cut points. We used standard categories for BMI (18.5 to 24.9, 25.0 to 29.9, Z30 kg/m 2 ) and alcohol intake (0.0, 1.0 to 14.9, 15.0 to 30.0 g/d). History of high blood pressure and family history of diabetes were categorized as present versus absent.
We calculated age-adjusted mean differences (95% confidence intervals, CIs) in plasma Ab42 levels and Ab42 to Ab40 ratio for insulin and each insulin-related variable in separate linear regression models (ie, insulin and the insulin-related variables were not mutually adjusted for each other as this would have resulted in over-control for insulin). Although levels of Ab42 and the ratio of Ab42 to Ab40 seem to be the most biologically relevant factors in AD, we also similarly considered plasma Ab40 alone in a separate regression model. To improve the normality of the distributions, we calculated the natural logarithm of the plasma Ab42 concentration, the ratio of the concentrations of Ab42 to Ab40, and Ab40 concentration. Then, to correct for the high between-plate variability in amyloid beta concentrations (described above), we calculated platespecific z-scores by dividing the difference between the participant's natural log Ab42 (or Ab42 to Ab40 ratio, or Ab40) value and the mean natural log Ab42 (or ratio, or Ab40) value among the samples on the same plate by the standard deviation.
Age was included as a continuous variable in all linear regression models. For all exposure variables except history of high blood pressure and family history of diabetes, we calculated P values for linear trend by including the continuous variable in the model. We excluded the few women with a BMI less than 18.5 kg/m 2 (n=10) from the analyses of BMI and the few women who reported consuming more than 30 g of alcohol per day (n=19) from the analyses of alcohol consumption.
RESULTS
Among the women in the study population, age at blood draw ranged from 59 to 69 years. Approximately 40% of the women had a BMI of 25 kg/m 2 or higher ( Table 1 ). The mean waist circumference was 80 cm. Overall, 24% of women reported no alcohol intake. Onethird of the women reported a history of high blood pressure, and 30% had a family history of diabetes.
In a univariate model, older age was significantly associated with lower plasma Ab42 to Ab40 ratio (mean difference per 1-year change in age: À 0.05; 95% CI, À0.09-À0.02, P=0.001). The association between age and Ab42 level was consistent with that for the ratio, but not statistically significant (mean difference: À 0.02; 95% CI, À0.06-0.02, P=0.36). After adjusting for age, the average levels of plasma Ab42 and Ab42 to Ab40 ratio were lower in women with higher levels of plasma insulin, but were not statistically significant (P for trend=0.50 and 0.14, respectively; Table 2 ). For plasma c-peptide, findings were somewhat stronger, indicating lower levels of Ab42 and Ab42 to Ab40 ratio in those with higher c-peptide levels, although again the results did not reach statistical significance (P for trend=0.06 and 0.07, respectively).
Several insulin-related factors were significantly associated with lower levels of circulating Ab42 and/or Ab42 to Ab40 ratio (Table 2) . Specifically, women with a family history of diabetes had significantly lower levels of both circulating Ab42 (P=0.03) and the ratio of Ab42 to Ab40 (P=0.04) than women without a family history of diabetes. There was a significant trend of decreasing plasma Ab42 with increasing waist circumference (P for trend=0.04). Women who were the least physically active had significantly lower plasma Ab42 levels than the most physically active women (P=0.04 comparing the bottom to the top quartile of physical activity). Women with a history of high blood pressure had lower plasma levels of Ab42 (P=0.02) than women without high blood pressure. Finally, plasma levels of Ab42 were significantly lower in women consuming 1 to 14.9 g of alcohol per day versus abstainers. The magnitude of the association was similar among the small number of women who reported consuming 15 to 30 g of alcohol per day, although not significant.
There was a suggestion of lower plasma levels of Ab42 in women with a BMI of 30 kg/m 2 or higher compared with lean women (BMI 18.5 to 24.9 kg/m 2 , P=0.06) and a suggestion of decreasing circulating Ab42 with increasing level of BMI (P for trend=0.11); however, these associations were not statistically significant.
In additional analyses, we examined the association between insulin, insulin-related factors, and plasma levels of Ab40. Age was not associated with Ab40 level in a univariate model (mean difference per 1-year change in age: 0.01; 95% CI, À0.02-0.05, P=0.46). There were no statistically significant associations between Ab40 and insulin or any of the insulin-related factors ( Table 2) , although there was a suggestion of lower Ab40 levels with increasingly higher physical activity (P for trend=0.07).
DISCUSSION
Among women without diabetes at late midlife, lower circulating levels of Ab42 or Ab42 relative to Ab40 were significantly associated with several factors related to insulin hypersecretion, [24] [25] [26] [27] including family history of diabetes, physical inactivity, high waist circumference, and high blood pressure, as well as moderate alcohol intake. Levels of Ab42 or Ab42 relative to Ab40 tended to be lower with higher c-peptide levels and high BMI, but these associations did not reach statistical significance. Circulating levels of Ab40 alone were not significantly associated with insulin or any of the insulin-related variables, although there was a suggestion of lower Ab40 with higher physical activity.
These findings are consistent with research indicating a relationship between hyperinsulinemia and less degradation of Ab in the brain as well as increased accumulation of Ab onto insoluble plaques. First, IDE is known to degrade insulin and Ab as well as several other small peptide hormones. 5 When insulin levels in the brain are high, typical of early stages of chronic peripheral hyperinsulinemia, 28 degradation of Ab is partially inhibited owing to competition with insulin for IDE. 5 In addition, higher levels of advanced glycation end products are associated with insulin resistance and appear to enhance aggregation of Ab onto plaques. 29 Both of these potential mechanisms could lead to accumulation of Ab in the brain and gradual sequestration into insoluble deposits, which would be expected to lead to lower levels of Ab42 and Ab42 relative to Ab40 in plasma.
Our data are consistent with small clinical research studies in which plasma Ab42 levels were lower in healthy adults acutely receiving insulin versus saline, either w10 women with body mass index <18.5 kg/m 2 were excluded from analyses of body mass index.
z19 women who reported consuming >30 g of alcohol per day were excluded from analyses of alcohol consumption.
MET indicates metabolic equivalent; SD, standard deviation.
intravenously or intranasally. 7, 8 For example, among 50 cognitively healthy older adults (mean age 70.5 y) who received an intravenous dose of insulin to produce a level typical of postprandial levels in insulin resistant adults, Kulstad et al 8 observed lower levels of plasma Ab42 compared with levels after an infusion of saline (P=0.03).
In the same study, plasma Ab40 appeared higher after insulin infusion (P=0.09), which is consistent with a lower ratio of plasma Ab42 to Ab40. These results suggest that elevated insulin levels in the periphery (and also in the brain) may impact clearance of Ab42 in the brain. Moreover, in a study of 530 adults aged 65 years and older, with and without AD, Mayeux et al 30 observed a modest inverse correlation between plasma Ab42 and BMI (r= À0.1, P=0.05), which is consistent with our results.
A unique strength of our study is its focus on factors related to Ab in healthy women at midlife, when evidence suggests intervention to prevent Ab accumulation in the brain will be most effective. 3, 31 However, several limitations of this study should also be considered. First, between-plate variability led to high overall CVs for the measurements of plasma Ab42 and Ab40, which could result in bias to the null when examining relations between plasma Ab and insulin and insulin-related factors. In particular, as the ratio of Ab42 to Ab40 incorporates random error in 2 variables, this may explain the higher P values generally observed for relations between insulin variables and the Ab42 to Ab40 ratio, as opposed to absolute Ab42 levels. Second, because we excluded women with diabetes from these analyses, the range of insulin levels in our sample was narrower than in À 0.27 ( À0.53, À0.01) À0.10 ( À 0.36, 0.16) À 0.21 ( À0.47, 0.04) Per 5 MET-h/wk increment 0.02 ( À0.00, 0.05) 0.00 ( À 0.02, 0.03) 0.02 ( À0.00, 0.05) P linear trendz 0.06 0.84 0.07 High blood pressure À 0.24 ( À0.43, À0.04) À0.15 ( À 0.34, 0.04) À 0.17 ( À0.36, 0.02) Alcohol, g/d 0.0 0.00 (reference) 0.00 (reference) 0.00 (reference) 1.0-14.9 (2.7) À 0.29 ( À0.51, À0.07) À0.18 ( À 0.40, 0.04) À 0.23 ( À0.45, À 0.01) 15.0-30.0 (19.7) À 0.28 ( À0.65, 0.09) À0.01 ( À 0.38, 0.36) À 0.37 ( À0.73, 0.00) Per 1 g/d increment À 0.01 ( À0.02, 0.01) 0.00 ( À 0.01, 0.02) À 0.01 ( À0.02, 0.01) P linear trendz 0.42 0.93 0.22 *For continuous variables that were categorized, we present the category range (median). wAnalyses used batch-specific z-scores of natural log Ab values. zP values for linear trend were calculated by including the continuous variable in the linear regression model. MET indicates metabolic equivalent.
the general population, which could lead to underestimation of the influence of insulin variables on circulating Ab levels. In addition, statistical power to detect associations was likely further limited because we conducted these analyses within a relatively small subset of women from the NHS cohort. Finally, as our study included primarily white women, it is possible that these findings are not generalizable to men or to minorities. In particular, further research to examine these associations in women and men of different racial and ethnic backgrounds is needed.
In conclusion, our findings suggest that peripheral insulin levels and/or factors associated with them may be important in regulating levels of soluble Ab42 in healthy women at late midlife, providing evidence that early intervention on insulin-related factors could be valuable in preventing Ab42 accumulation.
